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The  mixed  leukocyte  culture  (MLC)  has  been  used  for a  number  of  years  as  a 
model for  the  recognition  aspect  of  the  homograft  reaction.  There  appears  to  be  a 
significant  correlation  between  skin  graft  survival and  MLC  reactivity  (1).  Newer 
evidence  in  man  and  mouse  has  indicated  that  the  major  histocompatibility  loci 
may not be primarily involved in the stimulation phase but that loci associated with 
immune response (It) gene differences are more significant (2, 3). Recently Eijsvoogel 
et al. demonstrated a separate inheritance of the HL-A antigens and the determinants 
eliciting pronounced  MLC, probably by recombination,  which implied independence 
of this MLC system from both the LA and FOUR loci (4) ..... 
A number of different human  sera have been found that strongly inhibit the MLC 
reaction (5-7). This has been particularly evident for sera from patients with systemic 
lupus  erythematosus  (SLE)  where  evidence  has  been  obtained  that  antibodies  in- 
hibiting the responder cells in the MLC reaction are involved (8). Cytotoxic antibodies 
to T  cells have also been described in the sera of patients with SLE (9). The present 
studies  were  undertaken  in  an  attempt  to  define  the  specificity  of  the  antibodies 
involved in the MLC suppression.  Membrane antigens reacting with these antibodies 
were  investigated  by  the  method  of  lymphocyte  surface  radioiodination  (10).  One 
antigen on T  cells defined by this procedure appeared particularly relevant. 
Materials and Methods 
The method used for the unidirectional mixed leukocyte culture (MLC) has been performed 
in a microsystem as described by Hartzman et al.  (11). 
Absorbtions of normal and SLE sera were carried out routinely at two temperatures. 4 ml 
of heat-inactivated serum was incubated with equal volume of packed ABO red cells at 4°C, 
and then the supernatant with another 4 ml of packed cells at 37°C. In addition, certain SLE 
sera were absorbed further in the same fashion with isolated and pooled lymphocytes from pa- 
tients with chronic lymphocytic leukemia (CLL) having high peripheral blood counts; then 
with packed platelets pooled from ten different donors; and with allogeneic kidney cells.  Be- 
yond that a few sera were absorbed with allogeneic thymus or spleen cells or with buffy coat 
cells. 
For the enzymatic surface radioiodination  (SRI) a  modification of the method described 
by Baur et al. (10) using lactoperoxidase (Sigma Chemical Co., St. Louis, Mo.) to radioiodi 
nate the lymphocyte membranes was applied. For this procedure the lymphocyte populations 
were first kept in short-term cultures, which resulted in shedding of the autologous antibodies 
coated on the cells in vivo without loss of viability (8). The cells were then purified further 
by passage through a nylon-wool column as a second and through Sephadex G-10 columns as 
a third purification step to remove phagocytic cells. 
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The radioiodinated lymphocytes were solubilized  with the nonionic detergent NP-40 (Shell 
'Oil Company, New York). In a first step with rabbit antihuman  Ig and subsequent goat anti- 
rabbit Ig antibodies in excess, all lymphocyte-derived immunoglobulin molecules were pre- 
.cipitated out by this sandwich technique. The remaining supernatant was incubated first with 
~a normal or SLE serum or its IgG fraction and subsequently with the goat antihuman Ig anti- 
serum. The formed specific precipitate was solubilized and run on a 5% polyacrylamide gel 
,containing 0.1%  sodium dodecyl sulfate  (SDS). The radioactive bands obtained represent 
.antigen targets on the lymphocyte surface identified by specific antibody present in the lupus 
sera. Radiolabeled marker  proteins were: IgG (~150,000 daltons), "y-chains (~50,000  dal- 
tons), light chains (L~24,000 daltons), and beta-2-microglobulin (f12M~'~11,500  daltons). 
RESULTS 
Numerous experiments were carried out where the response of different lym- 
phocytes to stimulator cells in MLC reactions was compared in the presence of 
normal vs. SLE serum. Marked suppression was noted in certain SLE sera. This 
was maximal when the SLE cells were used as responders in the presence of the 
<orresponding sera. Fig. 1 illustrates one series of representative experiments. 
By testing 34 SLE patients in a  similar fashion it was found that 19 out of 
these showed an impaired MLC reactivity and 7 out of the 19 gave a complete 
inhibition of the MLC. The SLE sera involved primarily in this suppression of 
cell-mediated immunity were also able to block a number of allogeneic lympho- 
cyte combinations of normal persons. In comparing the blocking capacity and 
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Fro. 1. Reactivity and kinetics of unidirectional MLC reactions all triggered by the same 
stimulating lymphocyte population A. Upper curve (O--O) represents that for normal re- 
sponder lymphocytes, N, in  normal AB serum; middle curve ( •-- • ) is that for SLE responder 
cells, Go, in normal AB serum; and lower curve (A--A) is that for SLE responder cells, GO, 
in SLE se um GO. Complete suppression is noted in the latter case. 
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the cytotoxic potential of the lupus sera tested,  a  discrepancy between these 
two functions became apparent in vitro with some sera showing a strong MLC 
suppressive but no lymphocytotoxic effect. Considerable evidence was obtained 
by gel filtration of the SLE sera on Sephadex G-200 and by Pevikon block elec- 
trophoresis,  indicating that  the main blocking activity in the  MLC  reaction 
was due to antibodies of the IgG class. 
Fig. 2 A  illustrates the lymphocyte surface profile obtained from the periph- 
eral blood lymphocytes of SLE patient Har on SDS acrylamide electrophoresis 
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Fro. 2. SDS polyacrylamide gel patterns,  representing target surfac~ radioiodination pro- 
files obtained from membranes of SLE peripheral blood lymphocytes using the corresponding 
SLE serum as the antiserum  to precipitate  the membrane components. The lower curve A 
(0--0)  shows the pattern with the unabsorbed antiserum; the upper curve B  (Q--Q) is 
that for the SLE serum absorbed with B cells, platelets, etc. as described in text. The absorbed 
serum, which still inhibits strongly the MLC reaction, shows a major low mol wt component 
and a minor one of higher mol wt; control sera (X-X-X), not inhibitory in MLC and used 
in the same fashion, did not show these components. 1024  WERNET  AND  KUNKEL  BRIEF  DEFINITIVE  REPORT 
using the autologous serum as the reactive antiserum. Four different targets can 
be identified as separate peaks with  the  SLE  serum  Har  that  do not  appear 
with  the  control  serum  that  was  nonsuppressive in  the  MLC  system.  From 
these experiments and others where normal peripheral blood lymphocytes were 
used as targets, the impression was gained that active SLE sera contain a whole 
group  of  different  antibodies  directed  against  different  lymphocyte  surface 
structures.  Certain SLE sera were thoroughly absorbed with B  cells, platelets, 
etc.  to remove HL-A and other antibodies as described under  Materials and 
Methods. The absorbed sera were still strongly suppressive in the MLC when 
the  autologous  lymphocytes  were  used  as  the  responder  population.  Direct 
evidence against involvement of HL-A antibodies was shown by the continued 
blocking effect of absorbed SLE serum Har using an HL-A identical but MLC 
reacting lymphocyte population from  an unrelated donor  as stimulator cells. 
Fig. 2 B  shows that this absorbed serum localized primarily one labeled surface 
structure at about Fraction number 50. As can  be calculated from the approxi- 
mative position of included marker proteins this peak corresponds to a molecu- 
lar weight (mol wt) of about 15,000  daltons. With the exception of a minor peak 
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FIG. 3. SDS polyacrylamide gel electrophoresis  pattern of human thymocytes (A) and a 
CLL - "B  ceil" population (B) using unabsorbed SLE serum  Har (0--0)  and normal AB 
serum (X--X). Marker positions are included as in Fig. 2. In A only the small component at 
Fraction 50 is again evident, whereas this constituent is missing on "B lymphocytes" (B . WERNET  AND  KUNKEL  BRIEF DEFINITIVE REPORT  1025 
surface iodination pattern was obtained when allogeneic thymocytes were used 
together with the unabsorbed serum Har (Fig.  3 A); this was not seen for B 
cells (Fig. 3 B). 
Two other SLE sera that showed strong inhibition of MLC gave similar re- 
sults with specific reactivity for the low tool wt component. This was not ob- 
served for a limited number of sera that failed to inhibit  the MLC reaction. 
DISCUSSION 
It appears from the above experiments that T  cells and thymocytes possess 
a  low mol wt surface constituent  to which antibodies are sometimes found in 
human sera. Although most of the work was carried out on SLE sera, similar 
antibodies  were found in  sera from certain individuals  with other conditions 
and in certain allogeneic antisera. All  the sera showing reactivity against this 
material also blocked strongly the responder cells in the MLC reaction; various 
control  sera that did not  block the  MLC  failed  to  show such  specificity. It 
should be emphasized, however, that further sera need to be studied to establish 
firmly this  apparent  association.  Absorption  of  these  antisera  with  B  cells, 
platelets, and a variety of other cells failed to remove either the MLC-blocking 
effect or the reactivity for the low mol wt surface constituent. Absorption with 
thymocytes or spleen cells removed both effects. 
A  number of the absorbed sera that showed MLC inhibition  also showed a 
small higher mol wt component which may be significant. The possibility also 
remains that the blocking antibodies react with a constituent that is not solu- 
bilized by the ionic detergent utilized. Another possibility is that the antibodies 
that block the MLC reaction, even if they are directed to the low mol wt com- 
ponent,  are blocking because of reactivity to a  site close to or adjoining  the 
receptor site.  At  any rate,  irrespective of these various  possibilities,  the low 
mol wt antigen  clearly represents a  new  surface marker of  T  cells  to which 
autoantibodies are frequently produced. 
Current efforts are directed toward the preparative isolation of the low tool 
wt component so that its effect on the blocking antibodies can be determined 
directly. If this is successful, it appears possible that the low mol wt component 
participates in the recognitive phase involved in the MLC reaction. Recently 
antisera have been produced in mice that react with an antigen on a subpopula- 
tion of T  cells (12)  that appears related to the Ir gene product postulated by 
Benacerraf and McDevitt (13). 
SUMMARY 
Surface radioiodination of lymphocytes by the lactoperoxidase procedure has 
permitted demonstration of an assortment of different antibodies to lympho- 
cytes in the sera of patients with systemic lupus erythematosus. One type of 
antibody proved of special interest because it appeared to be associated with 
inhibition of the responder cells in the mixed leukocyte culture reactions. This 
reacted with an antigen on T  cells and thymocytes which on sodium dodeeyl 1026  WERNET  AND  KUNKEL  BRIEF  DEFINITIVE  REPORT 
sulfate  acrylamide gel electrophoresis  showed a  molecular  weight of approxi- 
mately 15,000 daltons. The possible relation of this antigen  to T  cell  receptors 
and products of immune response genes is discussed. 
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